Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

24 Dec, EOD - Indian

SENSEX 78472.87 (-0.09)

Nifty 50 23727.65 (-0.11)

Nifty Bank 51233 (-0.16)

Nifty IT 43668.9 (-0.36)

Nifty Midcap 100 57057.9 (-0.06)

Nifty Next 50 68857.25 (-0.05)

Nifty Pharma 22558.9 (-0.06)

Nifty Smallcap 100 18732.65 (0.24)

24 Dec, EOD - Global

NIKKEI 225 39336.39 (0.53)

HANG SENG 20098.29 (1.08)

S&P 6112.75 (0.05)

Cancel

BSE Code : 506820 | NSE Symbol : ASTRAZEN | ISIN : INE203A01020 | Industry : Pharmaceuticals |

(26-Nov-24 14:49) AstraZeneca gets CDSCO nod to import cancer drug, Lynparza
(19-Nov-24 12:11) AstraZeneca Pharma gains on plan to launch COPD drug
(14-Nov-24 12:34) AstraZeneca slumps as Q2 PAT slides 27% YoY to Rs 38 cr
(14-Nov-24 07:49) Astrazeneca Pharma India standalone net profit declines 26.62% in the September 2024 quarter
(25-Oct-24 16:11) Astrazeneca Pharma India to announce Quarterly Result
(24-Sep-24 14:30) Volumes spurt at Astrazeneca Pharma India Ltd counter
(24-Sep-24 12:00) Astrazeneca Pharma India Ltd leads gainers in 'A' group
(24-Sep-24 08:54) Astrazenenca Pharma gets CDSCO nod to import Durvalumab solutions
(08-Aug-24 16:08) AstraZeneca slumps on recording dismal Q1 performance
(08-Aug-24 15:40) Astrazeneca Pharma India reports standalone net loss of Rs 11.79 crore in the June 2024 quarter

1 2 3 4 5 6 7 8 9 10

Astrazeneca Pharma India Ltd